RSS-Feed abonnieren

DOI: 10.4103/0974-2727.154782
Role of Needle Aspiration in Diagnosis and Management of Suppurative Bacille Calmette–Guerin Adenitis: An Institutional Study of 30 Cases
Source of Support: Nil.
ABSTRACT
Context: Regional lymphadenitis is the most common complication of bacille Calmette-Guerin (BCG) vaccination. Most of the BCG lymphadenitis cases are nonsuppurative, but some suppurate and follow abscess formation, rupture, ulceration and cicatrization. Needle aspiration is the rapid, safe and cost-effective method for diagnosis as well as management of suppurative BCG adenitis.
Aims: The aims of the present study were to assess the clinical and cytological spectrum of BCG lymphadenitis and to evaluate the role of needle aspiration in the management of suppurative BCG lymphadenitis.
Settings and Design: We have approached every cases of ipsilateral axillary lymphadenopathy having history of BCG vaccination. We designed to aspirate the suppurative axillary lymph nodes and follow-up of nonsuppurative cases.
Subjects and Methods: 30 cases of BCG adenitis were studied during a period of 2 years. 12 cases of suppurative lymphadenitis were approached by needle aspiration and cytologically evaluated, and all the cases were followed-up for 12 weeks after diagnosis. Anti-tubercular drugs were not applied, and surgical excision was reserved for nonhealing lesions.
Statistical Analysis Used: Data tables.
Results: Ipsilateral axillary lymph nodes were commonest site and none had constitutional symptoms. Acid-fast bacilli were detected in 11 (91.67%) cases of suppurative BCG lymphadenitis. On follow-up all nonsuppurative adenitis were resolved spontaneously, and 8 suppurative lymphadenitis cases were resolved after 4 weeks of needle aspiration. Four cases needed repeat aspiration among which 3 resolved in 8 weeks, and one needed surgical excision.
Conclusions: We recommend needle aspiration as a simple, safe, chief and effective modality, which helps in diagnosis as well as in management of suppurative BCG lymphadenitis.
Publikationsverlauf
Artikel online veröffentlicht:
19. April 2020
© 2015.
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
REFERENCES
- 1 Behjati B, Ayatoallahi J. Post BCG lymphadenitis in vaccinated infants in Yazd, Iran. Iran J Pediatr 2008;18:351-6.
- 2 Goraya JS, Virdi VS. Bacilli Calmette-Guerin lymphadenitis. Postgrad Med J Lond 2002;78:327-9.
- 3 Bannon MJ. BCG and tuberculosis. Arch Dis Child 1999;80:80-3.
- 4 Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: A review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 1990;68:93-108.
- 5 Bukhari E, Alzahrani M, Alsubaie S, Alrabiaah A, Alzamil F. Bacillus Calmette-Guerin lymphadenitis: A 6-year experience in two Saudi hospitals. Indian J Pathol Microbiol 2012;55:202-5.
- 6 Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994;71:446-7.
- 7 Abu Zeid AF, Dahabreh MM. Bacille Calmette-Guerin lymphadinitis: A single center experience. J R Med Serv 2010;17:64-7.
- 8 Lussier N, Bourgault AM, Gaudreau C, Turgeon P. A complication of BCG vaccine: A case of localized cutaneous abscess due to Mycobacterium bovis.. Can J Infect Dis 1999;10:257-9.
- 9 Park K. Park's Textbook of Preventive and Social Medicine. 22nd ed. Jabalpur, India: Banarsidas Bhanot Publishers; 2013. p. 166-84.
- 10 Mori T, Yamauchi Y, Shiozawa K. Lymph node swelling due to bacille Calmette-Guérin vaccination with multipuncture method. Tuber Lung Dis 1996;77:269-73.
- 11 O'Brien KL, Ruff AJ, Louis MA, Desormeaux J, Joseph DJ, McBrien M, et al. Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 1995;95:414-8.
- 12 Kuyucu N, Kuyucu S, Ocal B, Teziç T. Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guérin lymphadenitis. Pediatr Infect Dis J 1998;17:524-5.
- 13 Caglayan S, Arikan A, Yaprak I, Aksoz K, Kansoy S. Management of suppuration in regional lymph nodes secondary to BCG vaccination. Acta Paediatr Jpn 1991;33:699-702.
- 14 Nazir Z, Qazi SH. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management. J Ayub Med Coll Abbottabad 2005;17:16-8.
- 15 Helmick CG, D'Souza AJ, Goddard N. An outbreak of severe BCG axillary lymphadenitis in Saint Lucia, 1982-83. West Indian Med J 1986;35:12-7.
- 16 Yan JJ, Chen FF, Jin YT, Chang KC, Wu JJ, Wang YW, et al. Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analyses of pncA and oxyR. J Pathol 1998;184:96-102.
- 17 de Souza GR, Sant'Anna CC, Lapa e Silva JR, Mano DB, Bethlem NM. Intradermal BCG vaccination complications - Analysis of 51 cases. Tubercle 1983;64:23-7.
- 18 Caglayan S, Yegin O, Kayran K, Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional lymphadenitis following BCG vaccination? Am J Dis Child 1987;141:1213-4.
- 19 Noah PK, Pande D, Johnson B, Ashley D. Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guérin lymphadenitis and abscesses. Pediatr Infect Dis J 1993;12:136-9.
- 20 Close GC, Nasiiro R. Management of BCG adenitis in infancy. J Trop Pediatr 1985;31:286.